C-Path Press Kit
CONTACT: Rick Myers at The Critical Path Institute, +1-520-547-3440
Selected articles about C-Path and Dr. Raymond Woosley:
"18 Big Ideas to Fix Health Care Now"
Reader's Digest.com, October 2008
(Excerpt)
#7. Share Information to Fight Cancer
"Could it really be this simple? Get the FDA and the pharmaceutical industry to talk more openly so patients can get safer drugs more quickly and inexpensively. The nonprofit Critical Path Institute (C-Path) believes we can save money and lives by speeding up our nation's sluggish and costly drug-approval process.
One project under way: C-Path brought 18 drug, biotech, and diagnostic companies together (many of them fierce competitors) to collaborate on a major lung cancer trial. The 18 companies are hoping to develop mutually agreed-upon tests that would allow the FDA to get results in as little as a week rather than years, says Raymond Woosley, MD, president of C-Path."
The payoff: Speeding up the trial process could reduce the number of costly failed drugs and lower the price of prescription drugs in general.
The action plan: Visit c-path.org for more information.
"FDA Is Easing Way for Drug Cocktails"
The Wall Street Journal, March 19th, 2010
Click here for Article
"Dr. Raymond Woosley Provides Expert Testimony in Congressional Hearings"
The Earth Times, March 23, 2007
Click here for article
"Five Questions for Dr. Raymond L. Woosley; Terror Adds to Safety Issues Awaiting New F.D.A. Chief"
The New York Times, Sept. 29, 2002
Click here for article
"Need Is Seen for a Drug Safety Board"
The New York Times, by Denise Grady, Dec. 29, 1998
Click here for article
More about the Critical Path Initiative and the FDA
Dec. 16, 2005, press release from the FDA.
"FDA Announces Partnership with Critical Path Institute to Conduct Essential Research to Spur Medical Innovation: Safety Consortium Study and Community Pharmacy Network among First Projects"
Critical Path Institute, headquartered in Tucson, Arizona, with offices in Rockville, Maryland, was established in 2005 as a publicly funded, nonprofit research and education institute to enable collaborations between scientists from the FDA, industry and academia. Critical Path Institute's mission is to help implement the FDA's Critical Path Initiative by developing faster, safer and smarter pathways to new medical products.